An Update on the COGiTATE Phase II Study: Feasibility and Safety of Targeting an Optimal Cerebral Perfusion Pressure as a Patient-Tailored Therapy in Severe Traumatic Brain Injury

Jeanette Tas(Johannes Kepler University of Linz), Marcel Aries(University of Antwerp), Manuel Cabeleira(University of Cambridge), Erta Beqiri(University of Cambridge), Ari Ercole(National Institute for Health and Care Research), Geert Meyfroidt(KU Leuven), Bart Depreitere(KU Leuven), David Menon(University of Cambridge), Annalisa Liberti(Maastricht University Medical Centre), Joseph E. Donnelly(University of Kansas Medical Center), Peter J. Hutchinson(University of Cambridge), Marta Fedriga(University of Cambridge), Joanne Outtrim(University of Cambridge), Gert Bellen(Flemish Community), Chiara Robba(Ospedale Policlinico San Martino), Marek Czosnyka(Cambridge University Hospitals NHS Foundation Trust), D. Bruyninckx(Catholic University of America), C. R. van Kaam(Radboud University Nijmegen), Peter Smielewski(University of Cambridge), Cornelia Hoedemaekers
Acta neurochirurgica. Supplementum
January 1, 2021
Cited by 22


Related Papers